PARP6-dependent vimentin ADP-ribosylation prevents myofibroblast activation in cardiac fibrosis
This study identifies PARP6 as a cardioprotective enzyme that suppresses cardiac fibrosis by ADP-ribosylating vimentin to inhibit RhoA-mediated actin stress fiber formation and myofibroblast activation.